SLC38A2 and breast cancer: In breast cancer cells, SNAT2 can be induced by both HIF-1α and estrogen receptor-α (ER-α), the binding sites for both HIF-1α and ER-α being overlapped in cis-regulatory elements of the SNAT2 gene [195].